Navigation Links
Marshall Edwards Adds $2 Million in Private Placement
Date:12/29/2011

SAN DIEGO, Dec. 29, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that it has reached a definitive agreement with its majority shareholder, Novogen Limited, to sell common stock in a private placement for gross proceeds of $2 million, before deducting fees and expenses of the offering, through the sale of approximately 1.94 million shares of common stock. The offering is expected to close by tomorrow, December 30, 2011, subject to certain customary closing conditions.

The net proceeds from the offering will be used to continue development of Marshall Edwards' lead oncology drug candidates, including the submission of an Investigational New Drug (IND) application for ME-344 in the first quarter of 2012 and the completion of a Phase I clinical trial of intravenous ME-143 in patients with solid refractory tumors in the second quarter of 2012.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Marshall Edwards, Inc. nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company's lead programs focus on two families of small molecules that result in the inhibition of tumor cell metabolism. The first and most advanced is a NADH oxidase inhibitor program that includes lead candidate ME-143. The Company initiated a Phase I clin
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
6. Marshall Edwards Announces Private Placement
7. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
8. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
11. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... , CONCORD, Calif. , Feb. 3 Pulse Systems ... the Western United States . Effective February 1, 2010 , Diverse ... exclusive sales territory encompassing the states of California (except for the ... Oregon , Washington , Colorado , Utah , Idaho ...
... , VIENNA, Va. , Feb. 3 ... , Chief Executive Officer, will be presenting at the 2010 BIO ... the conference will take place February 8-9 at the ... be on Tuesday, February 9th , at 1:30 p.m. ...
Cached Medicine Technology:Pulse Systems Announces New Sales Representation in the Western United States 2Pulse Systems Announces New Sales Representation in the Western United States 3CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference 2
(Date:5/24/2013)... According to the new market research report “Micro Irrigation ... published by MarketsandMarkets, global micro irrigation system market expected ... year 2010 and is expected to reach $3,414.7 million ... 2011 to 2016. , Browse:, , ... , 370 pages and in-depth Table Of ...
(Date:5/24/2013)... Pittsburgh, PA (PRWEB) May 24, 2013 ... may be more likely to suffer from gastroesophageal reflux ... physicians reported in a study published today. , ... and Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel ... “These findings could be of great importance to individuals ...
(Date:5/24/2013)... 24, 2013 For the second consecutive ... Fresh Express Café to treat Tabitha Meals on Wheels ... their door. More than 400 meal recipients recently enjoyed ... restaurants, along with the rest of a well-balanced, nutritious ... to partner with the Tabitha Meals on Wheels team,” ...
(Date:5/24/2013)... May 24, 2013 With today’s levels of ... hunting for advice on the causes of weight gain and ... developed that suggest causes of weight gain and treatments that ... study was released by the Child Study Center at ... the childhood diagnosis of ADHD and the soring rates of ...
(Date:5/24/2013)... Today marks the launch of Destination Halifax’s latest ... The redesigned and enhanced Itinerary Builder will help visitors ... computer or mobile device that they can send, save, ... to fill in their date of arrival and length ... of vacation packages, accommodations, restaurants, and things to do ...
Breaking Medicine News(10 mins):Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:Runza® Delivers Sandwiches, Draws Smiles from Tabitha Meals on Wheels Clients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Help Patients with Weight Gain Linked to Childhood ADHD Lose Weight Fast 2Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2
... Steve TyrellSpecial Performance by Dancing With The Stars ... actress Bonnie Hunt will receive the "True ... Harvey Rosen will receive "The Duke" ... 24th annual Odyssey Ball. The yearly fundraising ...
... added section on hospital care and advice on drugs ... News) -- New guidelines for treatment of heart failure ... the American College of Cardiology, with a strong emphasis ... also on the treatment of blacks. , "The most ...
... Survey conducted by the Society of Corporate Compliance and ... In the face of reports on AIG bonuses it ... of the gifts employees can give and receive and ... a survey the Society of Corporate Compliance and Ethics ...
... Possis Acquisition and Patient Care Innovations WARRENDALE, Pa., ... over $600 million in 2008, an increase of ... (excluding the effect of the Possis Medical, Inc. ... and therapeutic medical devices, MEDRAD has achieved a ...
... Software Upgrade Enhances Company,s Lead in Data Quality, ... AnalysisPITTSBURGH, March 26 Neuro Kinetics, Inc. (NKI) ... evaluation equipment used worldwide for balance, vestibular and ... release version 6.7 of its proprietary VEST(TM) control ...
... (NYSE Amex: DPW ) today announced its financial ... December 31, 2008.Digital Power reported net income of $142,000 for ... income of $235,000 for the three months ended December 31, ... 2008, compared to operating income of $206,000 for the fourth ...
Cached Medicine News:Health News:John Wayne Cancer Institute Auxiliary Honors Award-Winning Actress Bonnie Hunt and Philanthropists Donna & Harvey Rosen at the 24th Annual Odyssey Ball 2Health News:New Guidelines for Treating Heart Failure 2Health News:New Guidelines for Treating Heart Failure 3Health News:Bonuses May be Big but Don't Expect a Lavish Dinner or Gift 2Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 2Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 3Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 4Health News:Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference 2Health News:Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 4
... Used for stone manipulation and ... Enhanced wire strength permits the ... more readily than standard flat-wire ... easy, ergonomic one-handed operation. Supplied ...
... manipulation and removal in the urinary tract. The ... its shape following extreme torsion. The unique tipless ... the basket to open at the base of ... design reduces the likelihood of mucosal damage and ...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r...
... Analyzer is an in vitro diagnostic ... chemistry parameters using Reflotron Test Tabs. It works ... rapid and reliable results while being easy to ... display and the profile can be printed out ...
Medicine Products: